Has Nitin Ohri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,478 in general payments to Nitin Ohri, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nitin Ohri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nitin Ohri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nitin Ohri, MD

Therapeutic Radiology · Philadelphia, PANPI 1346499431

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $41,761 of the $43,478 with a category attached, or 96.0%. 6 manufacturers reported payments, led by Merck at 45.3% of the total. Reporting peaked in 2019 at $16,285 and has fallen 99.9% since, to $21 in 2025.

$43,478in general payments, 2019–2025

Across 35 payments — averaging $1242.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$20K
AstraZeneca$17K
Regeneron$7K
Genentech USA, Inc.$285
Novocure Inc.$50
Novartis$24

$3,684,422in research payments, 2019–2025

Across 24 payments — averaging $153,518 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$3.2M
Regeneron$308K
AstraZeneca$127K
Reflexion Medical, Inc.$20K

What the payments were for

Consulting fees$41,76196%
Travel & lodging$1,0082%
Food & beverage$7092%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	15	$19,703
AstraZeneca	9	$16,826
Regeneron	6	$6,590
Genentech USA, Inc.	2	$285
Novocure Inc.	2	$50
Novartis	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KEYTRUDA$13,735
IMFINZI$9,438
LIBTAYO$6,590
TAGRISSO$3,901
Alecensa$158
TECENTRIQ$158
ROZLYTREK$158
GAVRETO$158
Avastin$127

How this compares

Too few therapeutic radiology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$330,047

Medicare patients

267

Services billed

1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$141

Paid to pharmacies, not to this prescriber.

Other therapeutic radiology in Philadelphia

Anish ButalaPhiladelphia$1K
Robert LustigPhiladelphia$181
Robert GoodmanPhiladelphia$17
Nalini MehtaErie$9K
Leila TchelebiHershey$2K
Carl JuengPittsburgh$876
Jerome DerdelState College$548
Norman SchulmanWilkes Barre$448
Camilo AlcosebaBethlehem$26

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →